GoodRx Holdings Q1 2024 Adj. EPS $0.08, Inline, Sales $197.880M Beat $196.082M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoodRx Holdings (NASDAQ:GDRX) reported Q1 2024 earnings of $0.08 per share, meeting analyst estimates and marking a 14.29% increase from the previous year. Sales reached $197.880M, exceeding expectations by 0.92% and showing a 7.55% increase from the previous year.
May 09, 2024 | 10:07 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GoodRx Holdings reported Q1 2024 earnings of $0.08 per share, in line with estimates, and sales of $197.880M, surpassing estimates. Year-over-year, earnings and sales increased by 14.29% and 7.55%, respectively.
Meeting earnings estimates and exceeding sales forecasts, especially with year-over-year growth in both metrics, is generally viewed positively by the market. This performance could lead to increased investor confidence in GoodRx Holdings, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100